BluePeak swirls online to new microsite

Article

Heidelberg Engineering has launched an informative microsite about BluePeak blue laser autofluorescence.

Heidelberg Engineering has launched an informative microsite about BluePeak blue laser autofluorescence. The technology is now available on most models of the SPECTRALIS device.

For more information about BluePeak technology, visit www.BluePeakExperience.com

Related Videos
Diana Do, MD, Professor of Ophthalmology, Byers Eye Institute, Stanford University, discusses the PHOTON study results as presented AAO
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
Dr Mary Elizabeth Hartnett speaks with David Hutton of Ophthalmology Times
Esen K. Akpek, MD, Professor at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, converses via zoom with David Hutton of Ophthalmology Times
Related Content
A DNA double-helix is captioned, "Infiltrating the retina: a new study on gene therapy for LHON"

Cellular evidence of retinal ganglion cell transfection after LHON treatment

December 1st 2023
Article

Data show transfection in both eyes despite unilateral injection

Rob Thornhill, CEO, Centricity Vision, at AAO 2023

AAO 2023: Company updates from Centricity Vision CEO Rob Thornhill

November 28th 2023
Article

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Rob Thornhill, CEO of Centricity Vision, spoke with the Ophthalmology Times team about developments in the company's ZEPTOLink IOL positioning systems.

A person holds a phone in their hand. Above the phone, icons such as a cross, a pill, a wheelchair and a syringe indicate they are looking at health information. Image credit: ©Monster Ztudio – stock.adobe.com

Harnessing digital media for enhanced patient engagement and outcomes

November 27th 2023
Article

Patients who received digital education demonstrated a better understanding of their disease and its management

Marco A. Zarbin, MD, PhD, Professor of Ophthalmology, Rutgers New Jersey Medical School

AAO 2023: Marco A. Zarbin, MD, PhD, provides analysis of the YOSEMITE and RHINE clinical trials

November 24th 2023
Article

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Marco A. Zarbin, MD, spoke with Ophthalmology Times about his team's post-hoc analysis of the YOSEMITE and RHINE clinical trials

Documents indicate a corporation filing for bankruptcy. Image credit: ©Minerva Studio – stock.adobe.com

Oxurion NV will file for bankruptcy following KALAHARI data release

November 20th 2023
Article

In the clinical trial, Oxurion’s novel PKal Inhibitor, THR-149, did not meet its primary endpoint

Image credit: ©arcyto – stock.adobe.com

The next frontier in cell therapy: An ethically responsible management model

November 20th 2023
Article

Infrastructure across Europe needs a major overhaul to optimise education and patient access in groundbreaking treatments

© 2023 MJH Life Sciences

All rights reserved.